Miniature Dosimeters Autonomously Monitor EMR Exposure
By MedImaging International staff writers Posted on 16 Jan 2020 |

Image: A prototype autonomous EMR dosimeter (Photo courtesy of NU)
A millimeter-scale, ultra-low-power wireless digital platform provides continuous electromagnetic radiation (EMR) dosimetry for time-managed, wireless consumer devices.
Developed at Northwestern University (NU; Evanston, IL, USA) and the Korea Advanced Institute of Science and Technology (KAIST; Daejeon, Republic of Korea), the miniaturized digital dosimeter provides continuous EMR monitoring in an autonomous mode at one or multiple wavelengths simultaneously, transmitting the data over long-range wireless protocols to standard consumer devices. A single button cell battery powers the unit over a multiyear life span, enabled by the combined use of a light-powered, accumulation mode of detection and a light-adaptive, ultralow-power circuit design.
The dosimeter includes an accumulation detection module (ADM) for dosimetry and a Bluetooth low energy (BLE) system on a chip for wireless communication. A key feature is that the built-in ADM can directly measure continuous dose exposure without power consumption. As a result, it remains in an ultra-low sleep mode in the absence of light while continuously monitoring dosage via the ADM. When the dose exceeded a threshold, the device briefly wakes up to wirelessly transmit exposure data using BLE protocols to a smartphone, and resets the ADM and quickly return to sleep mode.
The ADM also includes a photodiode, supercapacitor, and a metal oxide semiconductor field-effect transistor (MOSFET). The miniaturized forms of the device have already been tested on sunglass clips, earrings, and wristbands for personalized EMR exposure detection. Field studies have shown that the dosimeter is extremely efficient in monitoring short-wavelength blue light from indoor lighting and display systems, as well as ultraviolet (UV), visible, and infrared (IR) radiation from the sun. The study was published on December 13, 2109, in Science Advances.
“The key feature of the ADM is that it directly measures exposure dose in a continuous fashion, without any power consumption. By contrast, conventional digital approaches approximate dose through computational time integration across a series of brief measurements of intensity, each performed using active, battery-powered electronics,” concluded lead author Kyeongha Kwon, PhD, of NU and KAIST, and colleagues. “Lack of interface ports and mechanical switches and the absence of need for battery replacement allow hermetic sealing of device for waterproof, sweat-resistant, and wear-resistant capabilities.”
Overexposure or underexposure to EMR can accumulate with latent consequences; where excessive exposure to UV and blue light from the sun or emissions of tanning beds and cellphones, can have associated health risks. For instance, repetitive keratinocyte damage from chronic exposure to UV is fundamental to cause skin cancer. The shorter wavelengths of the visible spectrum can generate reactive oxygen species (ROS) in the skin to cause DNA damage, hyperpigmentation and inflammation, alongside collagen and elastin degradation. Blue light can cause photochemical damage in retinal tissue to accelerate age-related maculopathy and modulate retinal control of the human circadian rhythm to suppress melatonin secretion.
Related Links:
Northwestern University
Korea Advanced Institute of Science and Technology
Developed at Northwestern University (NU; Evanston, IL, USA) and the Korea Advanced Institute of Science and Technology (KAIST; Daejeon, Republic of Korea), the miniaturized digital dosimeter provides continuous EMR monitoring in an autonomous mode at one or multiple wavelengths simultaneously, transmitting the data over long-range wireless protocols to standard consumer devices. A single button cell battery powers the unit over a multiyear life span, enabled by the combined use of a light-powered, accumulation mode of detection and a light-adaptive, ultralow-power circuit design.
The dosimeter includes an accumulation detection module (ADM) for dosimetry and a Bluetooth low energy (BLE) system on a chip for wireless communication. A key feature is that the built-in ADM can directly measure continuous dose exposure without power consumption. As a result, it remains in an ultra-low sleep mode in the absence of light while continuously monitoring dosage via the ADM. When the dose exceeded a threshold, the device briefly wakes up to wirelessly transmit exposure data using BLE protocols to a smartphone, and resets the ADM and quickly return to sleep mode.
The ADM also includes a photodiode, supercapacitor, and a metal oxide semiconductor field-effect transistor (MOSFET). The miniaturized forms of the device have already been tested on sunglass clips, earrings, and wristbands for personalized EMR exposure detection. Field studies have shown that the dosimeter is extremely efficient in monitoring short-wavelength blue light from indoor lighting and display systems, as well as ultraviolet (UV), visible, and infrared (IR) radiation from the sun. The study was published on December 13, 2109, in Science Advances.
“The key feature of the ADM is that it directly measures exposure dose in a continuous fashion, without any power consumption. By contrast, conventional digital approaches approximate dose through computational time integration across a series of brief measurements of intensity, each performed using active, battery-powered electronics,” concluded lead author Kyeongha Kwon, PhD, of NU and KAIST, and colleagues. “Lack of interface ports and mechanical switches and the absence of need for battery replacement allow hermetic sealing of device for waterproof, sweat-resistant, and wear-resistant capabilities.”
Overexposure or underexposure to EMR can accumulate with latent consequences; where excessive exposure to UV and blue light from the sun or emissions of tanning beds and cellphones, can have associated health risks. For instance, repetitive keratinocyte damage from chronic exposure to UV is fundamental to cause skin cancer. The shorter wavelengths of the visible spectrum can generate reactive oxygen species (ROS) in the skin to cause DNA damage, hyperpigmentation and inflammation, alongside collagen and elastin degradation. Blue light can cause photochemical damage in retinal tissue to accelerate age-related maculopathy and modulate retinal control of the human circadian rhythm to suppress melatonin secretion.
Related Links:
Northwestern University
Korea Advanced Institute of Science and Technology
Latest Radiography News
- World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
- AI-Powered Chest X-Ray Detects Pulmonary Nodules Three Years Before Lung Cancer Symptoms
- AI Model Identifies Vertebral Compression Fractures in Chest Radiographs
Channels
MRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more